Hey there, bargain hunter. A 36% dividend cut, a CEO calling results “unacceptable,” a stock down roughly 10% this morning. This is exactly the kind of wreckage that gets value investors salivating. Before you reach for CPB, run the numbers.

Scoreboard

Q4 net sales came in at $2.1 billion, missing analyst expectations of $2.15 billion, while adjusted EPS of $0.39 matched forecasts but declined 37% year over year. Organic net sales fell 1% in the quarter, with snacks down 6% and meals and beverages up 3%. Adjusted gross margin contracted 190 basis points to 28.6% as inflation and supply chain costs rose. Full-year fiscal 2026 was worse: revenue decreased 5% to $9.7 billion, while adjusted EPS fell 27% to $2.17.

What Actually Happened

The underlying story in the fourth quarter was cost inflation and supply chain expenses, including tariffs, which ate into profitability. Inflation of about 5% to 6% and other supply-chain expenses partly offset productivity gains. The snacks segment, which includes Goldfish and Pepperidge Farm, is in a genuine hole. Meals and beverages performed better, helped by semi-scratch cooking trends and continued momentum at Rao’s, while snacks remained the weak spot with lower sales and lower earnings as competition stayed intense and consumers remained cautious.

The Leverage Problem

This is the number that stops most bargain conversations cold. At fiscal year-end, Campbell’s held approximately $394 million in cash and about $7.1 billion in debt, producing a net leverage ratio of 4.3 times. That is up from 3.6 times a year ago. The elevated leverage reflects both pressured earnings and the La Regina acquisition.

The company is launching an enterprise-wide savings program targeting $500 million in cost reductions by fiscal 2030 and aims to reduce leverage from 4.3 times to approximately three times. The dividend reset should reduce annual cash outflows by about $170 million for debt reduction, which is real money. Getting from 4.3x to 3x on a business guiding for lower sales and lower EBIT, though, is a multi-year slog.

Is It Cheap?

For fiscal 2027, Campbell’s expects adjusted EPS of $1.65 to $1.80, with a midpoint of $1.73 that trails analyst consensus of $1.90 by 9%. The company also projects net sales to decline 4% to 2% and adjusted EBIT to fall 12% to 7%. At roughly $22, CPB trades around 13x the midpoint of that guidance range. That sounds reasonable. The catch: those estimates do not account for any new tariffs, and the guidance itself was issued against a backdrop management called unacceptable.

Peer context matters. Among comparable packaged food names, CPB trades at a P/E of roughly 11.5x versus CAG at 10.1x and GIS at 8.2x on trailing earnings. The average analyst price target for CPB sits at $22.77, representing modest downside from current levels, based on 28 analysts. Bank of America has an Underperform rating with a target of $18. CPB is not the cheapest in the aisle.

Bull / Base / Bear

• Bull: Rao’s keeps growing double digits, snacks stabilize by mid-FY27, the $500 million cost program delivers ahead of schedule, and leverage falls faster than guided. At 13x a recovering $2.00+ EPS, shares re-rate toward $26.
• Base: Slow execution, snacks drag continues, inflation stays elevated. EPS lands near the low end of guidance at $1.65. At 12x, the stock drifts toward $20. The $1.00 annualized dividend yields about 4.5% at that price, but with little cushion.
• Bear: A tariff escalation or further consumer pullback drives sales below the guided range. The company’s own outlook reflects an external environment expected to remain volatile with another year of elevated inflation. At 4.3x leverage, any EBITDA miss tightens the balance sheet meaningfully. The 52-week low of $19.55 is close.

Action Plan

Do not buy CPB today on yield alone. A 4.5% yield at $22 on a company guiding sales lower is not a margin of safety; it is a signal that the balance sheet is still running hot. Fiscal 2026 operating cash flow was $1.0 billion, down about $100 million from the prior year because of lower cash earnings, and FY27 is guided to be worse on an EBIT basis.

If you want exposure, watch for two things before adding: net leverage dropping below 4x on a quarterly report, and snacks organic sales turning flat or positive. Until both are in hand, any position should be small. Scale in at $20 or below if it gets there; that is where the risk/reward tilts more honestly in your favor.

Cheap Investor Checklist

• Net leverage at 4.3x: target below 4.0x before sizing up
• FY27 adjusted EPS guidance midpoint $1.73: watch for any downward revision
• Snacks organic sales: currently down 6%; needs to stop declining
• $500 million cost program: early deliverables expected in H1 FY27
• Rao’s momentum: must sustain double-digit growth to carry the meals segment
• Dividend now $1.00 annualized: confirmed, but any further cut would signal real distress
• Gross margin: track quarterly to see if it can recover toward 30%

Bottom Line

CPB near its 52-week low looks cheap on a screen. The debt load and a management team that used the word “unacceptable” to describe its own results say otherwise. If leverage comes down and snacks stop bleeding, this is a legitimate recovery story in a category consumers never stop buying. Right now, the guide has too many moving parts and too little margin for error. Watch, don’t reach.